Tango Therapeutics (TNGX) Leases: 2020-2025
Historic Leases for Tango Therapeutics (TNGX) over the last 4 years, with Sep 2025 value amounting to $36.6 million.
- Tango Therapeutics' Leases fell 9.52% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year decrease of 9.52%. This contributed to the annual value of $39.5 million for FY2024, which is 9.27% down from last year.
- Latest data reveals that Tango Therapeutics reported Leases of $36.6 million as of Q3 2025, which was down 2.59% from $37.6 million recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Leases peaked at $47.8 million during Q3 2022, and registered a low of $520,000 during Q2 2022.
- Its 3-year average for Leases is $41.5 million, with a median of $41.4 million in 2024.
- Its Leases has fluctuated over the past 5 years, first tumbled by 82.67% in 2021, then surged by 8,616.35% in 2023.
- Tango Therapeutics' Leases (Quarterly) stood at $1.3 million in 2021, then skyrocketed by 3,507.69% to $46.9 million in 2022, then declined by 7.23% to $43.5 million in 2023, then decreased by 9.27% to $39.5 million in 2024, then declined by 9.52% to $36.6 million in 2025.
- Its last three reported values are $36.6 million in Q3 2025, $37.6 million for Q2 2025, and $39.7 million during Q1 2025.